Is weight-based iv dosing of trastuzumab preferable to sc fixed-dose in some patients? a systematic scoping review

HIGHLIGHTS

• who: Hans-Christian Kolberg from the Department of Gynecology and Obstetrics, and Gynecologic Center, Marienhospital, Josef-Albers-Str70, Bottrop, Germany Department of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, Jonsson Comprehensive Center, Los Angeles, CA have published the article: Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review, in the Journal: (JOURNAL) of 26/08/2020
• what: The overall objective was to evaluate the appropriateness of fixed-dose SC trastuzumab across all patients with HER2-positive breast cancer. The aims of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.